NCT01774968 Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01771250 A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01769404 A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01769391 A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01769378 Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8) Status COMPLETED Phase PHASE3
NCT01765400 Platelet Inhibition in Patients With Systolic Heart Failure Status COMPLETED Phase PHASE4
NCT01763788 A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1/PHASE2
NCT01760005 Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT01754493 Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression Status COMPLETED Phase PHASE4
NCT01753856 Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis Status COMPLETED Phase PHASE4
NCT01751399 A Single Dose Study of LY2605541 in Participants With Liver Impairment Status COMPLETED Phase PHASE1
NCT01748552 A Study of LY2922083 in Healthy Participants and Participants With Diabetes Status COMPLETED Phase PHASE1
NCT01746017 A Study of LY2922470 in Healthy Participants and Participants With Diabetes Status COMPLETED Phase PHASE1
NCT01742767 Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC Status UNKNOWN Phase PHASE2
NCT01742091 A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women Status COMPLETED Phase PHASE1